Perfuze, a Galway-based medical device company, is advancing fast, safe, and predictable stroke treatment through innovation. Backed by the MARRS trial clinical evidence, the Millipede™ System’s unique corrugated design offers best-in-class deliverability and precise vessel matching for superior first-pass success. Combining powerful aspiration with reliable performance, the Perfuze portfolio helps physicians restore blood flow quickly and safely.
| Website | http://www.perfuze.com |
| Employees | 47 (36 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
reCAPTCHA
+8 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Biotechnology, Science and Engineering, Health Care, Medical, Medical Device |
| Keywords | Neurovascular Devices, Medical Technology, Neurology Devices, Vascular Devices, Interventional Neurology, Health Tech Startup, Brain Health Technology, Biomedical Engineering, Neuroscience, Medical Innovation, Blood Vessel Treatment, Therapeutic Devices, Surgical Devices, Precision Medicine, Healthcare Technology, Minimally Invasive Surgery, Medical Devices, Diagnostic Devices |
| Competitors | Boston Scientific, Chandler Regional Medical Center, Kennedy Krieger Institute, NeuroFlow, Cytonics Corporation, MindMaze, Nicolab, Pulse Therapeutics, Inc., Rise Health, Inc., Neurovative Technologies Inc. +30 more (view full list) |
Looking for a particular Perfuze employee's phone or email?
Wayne Allen is the CEO and Co-founder of Perfuze.
36 people are employed at Perfuze.